Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David N Assis

Showing results (41-50 of 60) with videos related to

Pageof 6
Sort By:
Hepatology (Baltimore, Md.)|December 22, 2019
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesCara L Mack, David Adams, David N Assis, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinomaChristopher L Bowlus, Lionel Arrivé, Annika Bergquist, et al.
Journal of Hepatology|April 20, 2019
Clinical utility of genomic analysis in adults with idiopathic liver diseaseAaron Hakim, Xuchen Zhang, Angela DeLisle, et al.
Hepatology (Baltimore, Md.)|January 25, 2023
Reply: Insurance should cover vancomycin for primary sclerosing cholangitisChristopher L Bowlus, Lionel Arrivé, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitisLeina S Alrabadi, Anne Dutton, Anahita Rabiee, et al.
Hepatology (Baltimore, Md.)|February 2, 2023
Reply: Living donor liver transplantation for people with PSCLisa M Forman, Gonzalo Sapisochin, David N Assis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022Romée J A L M Snijders, David N Assis, Ye H Oo, et al.
Journal of Clinical Gastroenterology|July 19, 2016
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot StudyDavid N Assis, Osama Abdelghany, Shi-Ying Cai, et al.
Hepatology Communications|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registryRichard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Hepatology (Baltimore, Md.)|August 6, 2013
The role of macrophage migration inhibitory factor in autoimmune liver diseaseDavid N Assis, Lin Leng, Xin Du, et al.
Pageof 6

Showing results (41-50 of 60) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|December 22, 2019
Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver DiseasesCara L Mack, David Adams, David N Assis, et al.
Hepatology (Baltimore, Md.)|September 9, 2022
AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinomaChristopher L Bowlus, Lionel Arrivé, Annika Bergquist, et al.
Journal of Hepatology|April 20, 2019
Clinical utility of genomic analysis in adults with idiopathic liver diseaseAaron Hakim, Xuchen Zhang, Angela DeLisle, et al.
Hepatology (Baltimore, Md.)|January 25, 2023
Reply: Insurance should cover vancomycin for primary sclerosing cholangitisChristopher L Bowlus, Lionel Arrivé, Annika Bergquist, et al.
JHEP Reports : Innovation in Hepatology|April 18, 2022
Mindfulness-based stress reduction may decrease stress, disease activity, and inflammatory cytokine levels in patients with autoimmune hepatitisLeina S Alrabadi, Anne Dutton, Anahita Rabiee, et al.
Hepatology (Baltimore, Md.)|February 2, 2023
Reply: Living donor liver transplantation for people with PSCLisa M Forman, Gonzalo Sapisochin, David N Assis, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2023
Research gaps and opportunities in autoimmune hepatitis-Results of the international autoimmune hepatitis group research workshop 2022Romée J A L M Snijders, David N Assis, Ye H Oo, et al.
Journal of Clinical Gastroenterology|July 19, 2016
Combination Therapy of All-Trans Retinoic Acid With Ursodeoxycholic Acid in Patients With Primary Sclerosing Cholangitis: A Human Pilot StudyDavid N Assis, Osama Abdelghany, Shi-Ying Cai, et al.
Hepatology Communications|May 14, 2025
Treatment of pruritus in primary sclerosing cholangitis: Analysis of the consortium for autoimmune liver disease registryRichard Dean, Maryam Yazdanfar, Joseph Zepeda, et al.
Hepatology (Baltimore, Md.)|August 6, 2013
The role of macrophage migration inhibitory factor in autoimmune liver diseaseDavid N Assis, Lin Leng, Xin Du, et al.
Pageof 6